Ticker Details
Wave Life Sciences Ltd. Ordinary Shares WAVE Life Sciences Ltd is a preclinical therapeutics developer in Singapore. Its pipeline of drugs is intended to cure rare genetic disorders such as Huntington, duchenne muscular dystrophy (DMD) and inflammatory bowel disease.
IPO Date:	November 11, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$2.51B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 3.34%
Avg Daily Range (30 D):	$0.35 | 2.59%
Avg Daily Range (90 D):	$0.49 | 3.95%

Institutional Daily Volume
Avg Daily Volume:	.64M
Avg Daily Volume (30 D):	2.89M
Avg Daily Volume (90 D):	5.07M

Trade Size
Avg Trade Size (Sh.):	108
Avg Trade Size (Sh.) (30 D):	99
Avg Trade Size (Sh.) (90 D):	115

Institutional Trades
Total Institutional Trades:	1,461
Avg Institutional Trade:	$1.63M
Avg Institutional Trade (30 D):	$2.3M
Avg Institutional Trade (90 D):	$2.11M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.05M
Avg Closing Trade (30 D):	$3.8M
Avg Closing Trade (90 D):	$3.84M
Avg Closing Volume:	196.64K

News

Feb 2, 2026 @ 7:16 PM Wave Life Sciences Reclaims Rare Disease Drug From... Source: Vandana Singh

Dec 11, 2025 @ 7:01 AM Golden Cross Alert: 3 Stocks With Major Upside Pot... Source: Chris Markoch

Dec 10, 2025 @ 2:50 AM Wave Life Sciences Prices Upsized $350 Million Pub... Source: Wave Life Sciences

Dec 10, 2025 @ 12:19 AM Why Wave Life Sciences Stock Crushed it Again Toda... Source: Eric Volkman

Dec 8, 2025 @ 11:30 PM Why Wave Life Sciences Stock Vaulted 146% Higher o... Source: Eric Volkman

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-.65	$-.32	$-.31
Diluted EPS	$-.65	$-.32	$-.31
Revenue	$109.23M	$7.61M	$8.7M
Gross Profit
Net Income / Loss	$-121.95M	$-53.85M	$-50.47M
Operating Income / Loss	$-135.95M	$-56.35M	$-52.76M
Cost of Revenue
Net Cash Flow	$-114.65M	$-12.22M	$-34.63M
PE Ratio